United Therapeutics Corp
NASDAQ:UTHR
Revenue Breakdown
Breakdown by Geography
United Therapeutics Corp
Total Revenue:
2.3B
USD
|
United States:
2.2B
USD
|
Rest-Of-World:
125.3m
USD
|
Breakdown by Segments
United Therapeutics Corp
Total Revenue:
2.3B
USD
|
Total Tyvaso:
1.2B
USD
|
Tyvaso Dpi:
731.1m
USD
|
Nebulized Tyvaso:
502.6m
USD
|
Remodulin:
494.8m
USD
|
Orenitram:
359.4m
USD
|
Unituxin:
198.9m
USD
|
Adcirca:
28.9m
USD
|
Other:
11.8m
USD
|